Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

53.84
-0.1000-0.19%
Post-market: 53.72-0.1200-0.22%18:55 EDT
Volume:3.03M
Turnover:164.53M
Market Cap:109.34B
PE:14.41
High:54.75
Open:54.23
Low:53.79
Close:53.94
52wk High:61.70
52wk Low:32.38
Shares:2.03B
Float Shares:1.95B
Volume Ratio:0.59
T/O Rate:0.16%
Dividend:1.75
Dividend Rate:3.25%
EPS(TTM):3.74
EPS(LYR):3.74
ROE:43.31%
ROA:9.79%
PB:5.03
PE(LYR):14.41

Loading ...

Citi Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Mar 05

GSK Discloses ADS Purchase by Chief People Officer Under Pension Plan

TIPRANKS
·
Mar 04

GSK completes acquisition of Rapt Therapeutics

TIPRANKS
·
Mar 03

GSK Buys RAPT Therapeutics to Bolster Long-Acting Food Allergy Pipeline

TIPRANKS
·
Mar 03

GSK Continues Buyback With £10.9m Treasury Share Purchase

TIPRANKS
·
Mar 03

GSK price target raised to 1,700 GBp from 1,600 GBp at Morgan Stanley

TIPRANKS
·
Mar 03

GSK’s RTS,S Malaria Vaccine Study Nears the Finish Line With Fresh 2026 Update

TIPRANKS
·
Mar 03

J.P. Morgan Sticks to Their Sell Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Mar 02

GSK Expands Share Buyback, Lifts Treasury Stock to Nearly 6% of Voting Rights

TIPRANKS
·
Mar 02

GSK Discloses Dividend-Funded ADS Acquisition by U.S. President Martinez-Davis

TIPRANKS
·
Feb 28

GSK Slips Thursday, Underperforms Market

Dow Jones
·
Feb 27

Jefferies Sticks to Their Buy Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Feb 26

GSK’s Bepirovirsen Wins First Global Regulatory Review in Japan for Chronic Hepatitis B

TIPRANKS
·
Feb 26

GSK’s Linerixibat Wins Priority Review in China for PBC-Related Itch

TIPRANKS
·
Feb 26

ViiV Healthcare reports ‘positive’ efficacy data from Phase IIb EMBRACE study

TIPRANKS
·
Feb 26

GSK Discloses Pension Plan ADS Purchase by Chief People Officer

TIPRANKS
·
Feb 26

GSK Expands February 2026 Share Buyback, Lifts Treasury Holdings to Nearly 6%

TIPRANKS
·
Feb 25

Barclays Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Feb 25

GSK Expands Pipeline With $950 Million Pulmonary Hypertension Power Play

Benzinga_recent_news
·
Feb 25

GSK agrees to acquire 35Pharma Inc. for $950M

TIPRANKS
·
Feb 25